I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Duration of SARS-CoV-2 Immune Responses Up to Six Months Fo..:
Marking, Ulrika
;
Havervall, Sebastian
;
Greilert-Norin, Nina
...
Vaccines, 2022, 10:3,. , 2022
Link:
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-472753
RT Journal T1
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
UL https://suche.suub.uni-bremen.de/peid=base-ftuppsalauniv:oai:DiVA.org:uu-472753&Exemplar=1&LAN=DE A1 Marking, Ulrika A1 Havervall, Sebastian A1 Greilert-Norin, Nina A1 Ng, Henry A1 Blom, Kim A1 Nilsson, Peter A1 Phillipson, Mia A1 Hober, Sophia A1 Nilsson, Charlotta A1 Mangsbo, Sara A1 Christ, Wanda A1 Klingstrom, Jonas A1 Gordon, Max A1 Åberg, Mikael A1 Thalin, Charlotte PB Uppsala universitet, Institutionen för medicinsk cellbiologi; Uppsala universitet, Science for Life Laboratory, SciLifeLab; Uppsala universitet, Institutionen för farmaceutisk biovetenskap; Uppsala universitet, Koagulation och inflammationsvetenskap; Uppsala universitet, Klinisk kemi; Karolinska Inst, Dept Clin Sci, Danderyd Hosp, S-18288 Stockholm, Sweden.; Karolinska Inst, Dept Clin Sci, Danderyd Hosp, S-18288 Stockholm, Sweden.;Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden.; Karolinska Inst, Dept Clin Sci, Danderyd Hosp, S-18288 Stockholm, Sweden.;Publ Hlth Agcy Sweden, Dept Microbiol, S-17182 Solna, Sweden.; KTH Royal Inst Technol, Dept Prot Sci, SciLifeLab, S-11428 Stockholm, Sweden.; Publ Hlth Agcy Sweden, Dept Microbiol, S-17182 Solna, Sweden.;Karolinska Inst, Dept Lab Med, Div Clin Microbiol, S-17176 Stockholm, Sweden.; Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, S-14152 Stockholm, Sweden.; Publ Hlth Agcy Sweden, Dept Microbiol, S-1718... YR 2022 K1 COVID-19 K1 SARS-CoV-2 K1 SARS-CoV-2 vaccination K1 heterologous K1 immune response K1 duration K1 antibodies K1 humoral response K1 T-cells K1 immunity K1 immunology K1 Immunology in the medical area K1 Immunologi inom det medicinska området JF Vaccines, 2022, 10:3, LK http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-472753 DO http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-472753 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)